Locoregional recurrence negatively impacts both long‐term survival and quality of life for
several malignancies. For appropriate‐risk patients with an isolated, resectable, local …

Dealing with cancer is of importance due to enhanced incidence rate of this life-threatening
disorder. Chemotherapy is an ideal candidate in overcoming and eradication of cancer. To …

Breast cancer is the most common malignant disease in women worldwide, but the current
drug therapy is far from optimal as indicated by the high death rate of breast cancer patients …

The rapid development of nanotechnology provides alternative approaches to overcome
several limitations of conventional anti-cancer therapy. Drug targeting using functionalized …

Breast cancer (BC) is a highly prevalent disease, accounting for the second highest number
of cancer-related mortalities worldwide. The anthracycline doxorubicin (DOX), isolated from …

We herein review various pharmacological and clinical aspects of pegylated liposomal
doxorubicin (PLD), the first nanomedicine to be approved for cancer therapy, and discuss …

As per the WHO, every year around 2.1 million women are detected with breast cancer. It is
one of the most invasive cancer in women and second most among all, contributing around …

The delivery of therapeutics into sites of action by using cargo-delivery platforms potentially
minimizes their premature degradation and fast clearance from the bloodstream …

Despite the efforts that have been made in the field of breast cancer therapy, it is a leading
cause of cancer death in women and a major health problem. The current treatments …

Doxorubicin is a key treatment for breast cancer, but its effectiveness often comes with
significant side effects. Its actions include DNA intercalation, topoisomerase II inhibition, and …